NCT03976245 2024-11-29
Advanced Therapeutics in Rheumatoid Arthritis (RA)
London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's
Phase 4 Recruiting
Clinical Trials
13 trialsNCT01793519 2024-02-28
STARA
Georgetown University
Phase 4 Unknown
NCT04798287 2022-06-22
STAR-RA-Cancer
Brigham and Women's Hospital
Completed
NCT05379049 2022-05-18
TNF-alpha
University of Sulaimani
Unknown
NCT00837434 2021-09-22
Anti-TNF Agents for the Treatment of Rheumatoid Arthritis
National Institute of Allergy and Infectious Diseases (NIAID)
Phase 4 Completed
NCT02092467 2021-08-17
Safety Study Of Tofacitinib Versus Tumor Necrosis Factor (TNF) Inhibitor In Subjects With Rheumatoid Arthritis
Pfizer
Phase 4 Completed
NCT04115423 2020-09-10
A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab
Sungkyunkwan University
Unknown
NCT01060098 2020-01-18
T Cells and TNF (Tumor Necrosis Factor): The Impact of TNF Blockade
Imperial College London
Completed
NCT02778789 2019-09-26
Re-Bone
University of Erlangen-Nürnberg Medical School
Completed
NCT00357903 2017-02-09
Open-Label Extension Treatment With Etanercept (TNFR:Fc) for Participating Patients in Etanercept (TNFR:Fc) Clinical Trials
Amgen
Phase 3 Completed
NCT02109289 2017-02-07
Etanercept in Rheumatoid Arthritis and Vascular Inflammation
Innovaderm Research Inc.
Phase 4 Terminated
NCT01295151 2016-11-02
SWITCH
University of Leeds
Phase 4 Completed
NCT01009879 2013-07-02
Human Tumor Necrosis Factor Alpha (TNFa)-Induced Pre-B Cell Bone Marrow Emigrants
University of Pittsburgh
Phase 4 Withdrawn